US$ 26.24
approved glp-1 agonists Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care List of approved and pending
Description
Red meat

More recently, the FDA has approved several GLP-1 agonists for weight loss in people with obesity who do not have diabetes
Over 72 weeks patients without diabetes lost 15%, 19%, and 21% of body weight on the 5, 10, and 15 mg weekly SQ injections, respectively

Whats next for employers and GLP-1s

The move also ties in with efforts by the broader pharma industry to move away from the unpopular system of high list prices for medicines that are then subject to opaque rebates and reductions by supply chain middlemen like pharmacy benefit managers

Paragraph IV Certifications List
